Natural Products
| Catalog No. | Information |
| CFN60113 | Tyrphostin B42 (AG-490) |
| CFN60114 | GSK2606414 |
| CFN60115 | Irinotecan HCI Trihydrate |
| CFN60116 | RGFP966 |
| CFN60117 | Tazemetostat (EPZ-6438) |
| CFN60118 | JNK-IN-8 |
| CFN60119 | Osimertinib (AZD9291) |
| CFN60120 | SH-4-54 |
| CFN60121 | SB202190 (FHPI) |
| CFN60122 | Temsirolimus (CCI-779) |
| CFN60123 | Celecoxib |
| CFN60124 | Enzastaurin (LY317615) |
| CFN60125 | PP2 (AG 1879) |
| CFN60126 | Roscovitine (CYC202) |
| CFN60127 | Pomalidomide |
| CFN60128 | Lenalidomide (CC-5013) |
| CFN60129 | Tipifarnib (R115777) |
| CFN60130 | Stattic |
| CFN60131 | Birabresib (OTX015) |
| CFN60132 | Z-DEVD-FMK |
| CFN60133 | PD184352 (CI-1040) |
| CFN60134 | Fludarabine |
| CFN60135 | PD173074 |
| CFN60136 | Imatinib Mesylate (STI571) |
| CFN60137 | Daunorubicin HCl |
| CFN60138 | Acadesine (AICAR) |
| CFN60139 | Belnacasan (VX-765) |
| CFN60140 | SB216763 |
| CFN60141 | Doramapimod (BIRB 796) |
| CFN60142 | Cediranib (AZD2171) |
| CFN60143 | T0070907 |
| CFN60144 | Nocodazole |
| CFN60145 | Axitinib |
| CFN60146 | C646 |
| CFN60147 | ZM 447439 |
| CFN60148 | Sunitinib Malate |
| CFN60149 | SNS-032 (BMS-387032) |
| CFN60150 | Ferrostatin-1 |
| CFN95243 | Neoarctin B Reference standards. |
| CFN95244 | Henricine Reference standards. |
| CFN95245 | Sphenanlignan Reference standards. |
| CFN95246 | (-)-Cadin-4,10(15)-dien-11-oic acid Reference standards. |
| CFN95247 | Chamigrenol Chamigrenol is a promising candidate for the development of potent Na+/K+ ATPase inhibitors and antimicrobial agents. It inhibited the activities of Na+/K+-ATPase, with the IC50 value of 15.9 ± 0.54 μg/mL. |
| CFN95248 | Quasipanaxatriol Quasipanaxatriol can greatly enhance the cytotoxicity of the anti-cancer drugs in P388/ADM cells. |
| CFN95249 | Vicinin 2 Reference standards. |
| CFN60151 | SB525334 |
| CFN60152 | IC-87114 |
| CFN60153 | PI-103 |
| CFN60154 | PIK-75 HCl |
| CFN60155 | Bosutinib (SKI-606) |
